Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Jun 18:2024.03.26.586768.
doi: 10.1101/2024.03.26.586768.

Heterogeneity of morphometric similarity networks in health and schizophrenia

Affiliations

Heterogeneity of morphometric similarity networks in health and schizophrenia

Joost Janssen et al. bioRxiv. .

Update in

  • Heterogeneity of morphometric similarity networks in health and schizophrenia.
    Janssen J, Guil Gallego A, Díaz-Caneja CM, Gonzalez Lois N, Janssen N, González-Peñas J, Macias Gordaliza P, Buimer E, van Haren N, Arango C, Kahn R, Pol HEH, Schnack HG. Janssen J, et al. Schizophrenia (Heidelb). 2025 Apr 24;11(1):70. doi: 10.1038/s41537-025-00612-2. Schizophrenia (Heidelb). 2025. PMID: 40274815 Free PMC article.

Abstract

Introduction: Morphometric similarity is a recently developed neuroimaging phenotype of inter-regional connectivity by quantifying the similarity of a region to other regions based on multiple MRI parameters. Altered average morphometric similarity has been reported in psychotic disorders at the group level, with considerable heterogeneity across individuals. We used normative modeling to address cross-sectional and longitudinal inter-individual heterogeneity of morphometric similarity in health and schizophrenia.

Methods: Morphometric similarity for 62 cortical regions was obtained from baseline and follow-up T1-weighted scans of healthy individuals and patients with chronic schizophrenia. Cortical regions were classified into seven predefined brain functional networks. Using Bayesian Linear Regression and taking into account age, sex, image quality and scanner, we trained and validated normative models in healthy controls from eleven datasets (n = 4310). Individual deviations from the norm (z-scores) in morphometric similarity were computed for each participant for each network and region at both timepoints. A z-score ≧ than 1.96 was considered supra-normal and a z-score ≦ -1.96 infra-normal. As a longitudinal metric, we calculated the change over time of the total number of infra- or supra-normal regions per participant.

Results: At baseline, patients with schizophrenia had decreased morphometric similarity of the default mode network and increased morphometric similarity of the somatomotor network when compared with healthy controls. The percentage of patients with infra- or supra-normal values for any region at baseline and follow-up was low (<6%) and did not differ from healthy controls. Mean intra-group changes over time in the total number of infra- or supra-normal regions were small in schizophrenia and healthy control groups (<1) and there were no significant between-group differences.

Conclusions: In a case-control setting, a decrease of morphometric similarity within the default mode network may be a robust finding implicated in schizophrenia. However, normative modeling suggests that significant reductions and changes over time of regional morphometric similarity are evident only in a minority of patients.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr. Díaz-Caneja has received honoraria from Angelini and Viatris. Dr. Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen-Cilag, Lundbeck, Otsuka, Roche, Sage, Servier, Shire, Schering-Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda. Dr. Cahn has received unrestricted research grants from or served as an independent symposium speaker or consultant for Eli Lilly, Bristol-Myers Squibb, Lundbeck, Sanofi-Aventis, Janssen-Cilag, AstraZeneca, and Schering-Plough. The other authors report no financial relationships with commercial interests.

Figures

Figure A.
Figure A.
Eleven datasets were used in the study. Ten datasets were cross-sectional and included healthy participants. For each of these ten datasets, 90% of individuals were included in the training set and 10% were part of the test set. One longitudinal clinical dataset (two timepoints) included healthy controls and individuals with chronic schizophrenia. Of the healthy controls belonging to the longitudinal clinical dataset, 20% were included in the training set and 80% in the test set. All individuals with schizophrenia were included in the test set. The age distribution for each dataset within the training/test samples is shown. The table shows the descriptives per dataset. N, number of subjects.
Figure B.
Figure B.
Study overview. A. Ten cross-sectional datasets consisting of healthy individuals only and one longitudinal dataset consisting of healthy controls and individuals with chronic schizophrenia (utrecht) were used in the study. B. morphometric similarity matrices were constructed following established protocols using cortical thickness, cortical volume, surface area, mean curvature and Guassian curvature extracted for each cortical region (Seidlitz et al., 2018). C. Example centile plot from normative modeling of regional morphometric similarity of the left hemispheric superior frontal gyrus for assessing individual deviance (Z). Normative modeling was done following established protocols (Rutherford et al., 2022) using prediction on unseen test data following training of the model. D. Normative models of each cortical region were clustered based on their typical age-dependency. E. Cortical maps depicting percentage longitudinal change of extreme deviance below the norm, i.e. infra-normal deviance, in individuals with schizophrenia and healthy individuals. n, number of subjects, CT, cortical thickness; SA, surface area; CV, cortical volume; MC, mean curvature; GC, Gaussian curvature. MS, morphometric similarity.
Figure C.
Figure C.
Clustering of brain regions based on the typical age-dependency of regional morphometric similarity. A. The median normative morphometric similarity of the normative model of each cortical region was entered into a Principal Component Analysis (PCA). The first two components explaining 98.6% of the variance were selected. B. The Euclidean distance matrix was extracted from the PCA output and used for hierarchical clustering. A two cluster solution was determined optimal. C. Each plot shows the median normative fits for a cluster with the remaining normative fits in gray. The average fit across all fits belonging to a cluster is added in black. The cluster solution was also visualized on the cortex displaying the distribution of the two clusters across the cortex. L, left hemisphere, R, right hemisphere. The upper row are lateral views, the bottom row are medial views.
Figure D.
Figure D.
Violin plots of significant (FDR-corrected) differences in z-scores of morphometric similarity of two functional networks that differed significantly between the group of healthy controls and the group of individuals with schizophrenia at baseline.
Figure E.
Figure E.
Cortical maps showing the percentage of individuals with infra- and supra-deviance morphometric similarity per region, A) at baseline, B) at follow-up, and C) the change in percentage during follow-up (i.e., percentage at follow-up - percentage at baseline). A negative percentage means that the regional percentage of individuals with infra- or supra-normal deviance decreased during follow-up.

Similar articles

References

    1. Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, Fatouros-Bergman H, Flyckt L, Di Giorgio A, Haatveit B, Jönsson EG, Kirsch P, Lund MJ, Meyer-Lindenberg A, Pergola G, Schwarz E, Smeland OB, Quarto T, Zink M, Andreassen OA, Westlye LT, Karolinska Schizophrenia Project Consortium. 2019. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. JAMA Psychiatry 76:739–748. doi: 10.1001/jamapsychiatry.2019.0257 - DOI - PMC - PubMed
    1. Barbora Rehák Bučková, Charlotte Fraza, Rastislav Rehák, Marián Kolenič, Christian Beckmann, Filip Španiel, Andre Marquand, Jaroslav Hlinka. 2024. Using normative models pre-trained on cross-sectional data to evaluate longitudinal changes in neuroimaging data. bioRxiv 2023.06.09.544217. doi: 10.1101/2023.06.09.544217 - DOI
    1. Barth C, Kelly S, Nerland S, Jahanshad N, Alloza C, Ambrogi S, Andreassen OA, Andreou D, Arango C, Baeza I, Banaj N, Bearden CE, Berk M, Bohman H, Castro-Fornieles J, Chye Y, Crespo-Facorro B, de la Serna E, Díaz-Caneja CM, Gurholt TP, Hegarty CE, James A, Janssen J, Johannessen C, Jönsson EG, Karlsgodt KH, Kochunov P, Lois NG, Lundberg M, Myhre AM, Pascual-Diaz S, Piras F, Smelror RE, Spalletta G, Stokkan TS, Sugranyes G, Suo C, Thomopoulos SI, Tordesillas-Gutiérrez D, Vecchio D, Wedervang-Resell K, Wortinger LA, Thompson PM, Agartz I. 2023. In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysis. Mol Psychiatry 28:1159–1169. doi: 10.1038/s41380-022-01901-3 - DOI - PMC - PubMed
    1. Bedford SA, Lai M-C, Lombardo MV, Chakrabarti B, Ruigrok A, Suckling J, Anagnostou E, Lerch JP, Taylor M, Nicolson R, Stelios G, Crosbie J, Schachar R, Kelley E, Jones J, Arnold PD, Courchesne E, Pierce K, Eyler LT, Campbell K, Barnes CC, Seidlitz J, Alexander-Bloch AF, Bullmore ET, Baron-Cohen S, Bethlehem RAI, MRC AIMS Consortium and Lifespan Brain Chart Consortium. 2023. Brain-charting autism and attention deficit hyperactivity disorder reveals distinct and overlapping neurobiology. MedRxiv Prepr Serv Health Sci 2023.12.06.23299587. doi: 10.1101/2023.12.06.23299587 - DOI
    1. Bethlehem R a I, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, Adler S, Alexopoulos GS, Anagnostou E, Areces-Gonzalez A, Astle DE, Auyeung B, Ayub M, Bae J, Ball G, Baron-Cohen S, Beare R, Bedford SA, Benegal V, Beyer F, Blangero J, Blesa Cábez M, Boardman JP, Borzage M, Bosch-Bayard JF, Bourke N, Calhoun VD, Chakravarty MM, Chen C, Chertavian C, Chetelat G, Chong YS, Cole JH, Corvin A, Costantino M, Courchesne E, Crivello F, Cropley VL, Crosbie J, Crossley N, Delarue M, Delorme R, Desrivieres S, Devenyi GA, Di Biase MA, Dolan R, Donald KA, Donohoe G, Dunlop K, Edwards AD, Elison JT, Ellis CT, Elman JA, Eyler L, Fair DA, Feczko E, Fletcher PC, Fonagy P, Franz CE, Galan-Garcia L, Gholipour A, Giedd J, Gilmore JH, Glahn DC, Goodyer IM, Grant PE, Groenewold NA, Gunning FM, Gur RE, Gur RC, Hammill CF, Hansson O, Hedden T, Heinz A, Henson RN, Heuer K, Hoare J, Holla B, Holmes AJ, Holt R, Huang H, Im K, Ipser J, Jack CR, Jackowski AP, Jia T, Johnson KA, Jones PB, Jones DT, Kahn RS, Karlsson H, Karlsson L, Kawashima R, Kelley EA, Kern S, Kim KW, Kitzbichler MG, Kremen WS, Lalonde F, Landeau B, Lee S, Lerch J, Lewis JD, Li J, Liao W, Liston C, Lombardo MV, Lv J, Lynch C, Mallard TT, Marcelis M, Markello RD, Mathias SR, Mazoyer B, McGuire P, Meaney MJ, Mechelli A, Medic N, Misic B, Morgan SE, Mothersill D, Nigg J, Ong MQW, Ortinau C, Ossenkoppele R, Ouyang M, Palaniyappan L, Paly L, Pan PM, Pantelis C, Park MM, Paus T, Pausova Z, Paz-Linares D, Pichet Binette A, Pierce K, Qian X, Qiu J, Qiu A, Raznahan A, Rittman T, Rodrigue A, Rollins CK, Romero-Garcia R, Ronan L, Rosenberg MD, Rowitch DH, Salum GA, Satterthwaite TD, Schaare HL, Schachar RJ, Schultz AP, Schumann G, Schöll M, Sharp D, Shinohara RT, Skoog I, Smyser CD, Sperling RA, Stein DJ, Stolicyn A, Suckling J, Sullivan G, Taki Y, Thyreau B, Toro R, Traut N, Tsvetanov KA, Turk-Browne NB, Tuulari JJ, Tzourio C, Vachon-Presseau É, Valdes-Sosa MJ, Valdes-Sosa PA, Valk SL, van Amelsvoort T, Vandekar SN, Vasung L, Victoria LW, Villeneuve S, Villringer A, Vértes PE, Wagstyl K, Wang YS, Warfield SK, Warrier V, Westman E, Westwater ML, Whalley HC, Witte AV, Yang N, Yeo B, Yun H, Zalesky A, Zar HJ, Zettergren A, Zhou JH, Ziauddeen H, Zugman A, Zuo XN, 3R-BRAIN, AIBL, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Repository Without Borders Investigators, CALM Team, Cam-CAN, CCNP, COBRE, cVEDA, ENIGMA Developmental Brain Age Working Group, Developing Human Connectome Project, FinnBrain, Harvard Aging Brain Study, IMAGEN, KNE96, Mayo Clinic Study of Aging, NSPN, POND, PREVENT-AD Research Group, VETSA, Bullmore ET, Alexander-Bloch AF. 2022. Brain charts for the human lifespan. Nature 604:525–533. doi: 10.1038/s41586-022-04554-y - DOI - PMC - PubMed

Publication types